Table 2:

Microbleeds (yes versus no) and white matter microstructure integrity^{^a}

	FA		MD		Axial Diffusivity		Radial Diffusivity
	β	P	β	P	β	P	β	P
Model 1	−0.450 (−0.616 to −0.285)	<.001	0.433 (0.282−0.584)	<.001	0.378 (0.221−0.535)	<.001	0.446 (0.295−0.597)	<.001
Model 2	−0.433 (−0.597 to −0.269)	<.001	0.420 (0.271−0.570)	<.001	0.368 (0.212−0.524)	<.001	0.432 (0.282−0.581)	<.001
Model 3	−0.238 (−0.394 to −0.083)	.003	0.204 (0.068−0.340)	.003	0.165 (0.019−0.310)	.026	0.217 (0.081−0.352)	.002
Model 4	−0.241 (−0.396 to −0.086)	.002	0.206 (0.070−0.342)	.003	0.167 (0.021−0.312)	.025	0.218 (0.083−0.354)	.002

Note:—β indicates regression coefficient.
↵a Values represent differences in z scores of mean FA, MD, axial diffusivity, and radial diffusivity of NAWM for the presence of any microbleeds compared with no microbleeds. Model 1: adjusted for age and sex; model 2: same as model 1, additionally adjusted for hypertension, hyperlipidemia, smoking, diabetes; model 3: adjusted for age, sex, lacunes, and white matter hyperintensity volume (log-transformed); model 4: adjusted for sex, cardiovascular risk factors as in model 2, and CSVD imaging markers as in model 3.